• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 Beta 和 Delta 变体通过增加交叉反应性触发 Fc 效应子功能。

SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity.

机构信息

National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg 2131, South Africa.

SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg 2001, South Africa.

出版信息

Cell Rep Med. 2022 Jan 17;3(2):100510. doi: 10.1016/j.xcrm.2022.100510. eCollection 2022 Feb 15.

DOI:10.1016/j.xcrm.2022.100510
PMID:35233544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8761540/
Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VOCs) exhibit escape from neutralizing antibodies, causing concern about vaccine effectiveness. However, while non-neutralizing cytotoxic functions of antibodies are associated with improved disease outcome and vaccine protection, Fc effector function escape from VOCs is poorly defined. Furthermore, whether VOCs trigger Fc functions with altered specificity, as has been reported for neutralization, is unknown. Here, we demonstrate that the Beta VOC partially evades Fc effector activity in individuals infected with the original (D614G) variant. However, not all functions are equivalently affected, suggesting differential targeting by antibodies mediating distinct Fc functions. Furthermore, Beta and Delta infection trigger responses with significantly improved Fc cross-reactivity against global VOCs compared with D614G-infected or Ad26.COV2.S-vaccinated individuals. This suggests that, as for neutralization, the infecting spike sequence affects Fc effector function. These data have important implications for vaccine strategies that incorporate VOCs, suggesting these may induce broader Fc effector responses.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起关注的变异株(VOCs)表现出对中和抗体的逃逸,这引起了人们对疫苗有效性的担忧。然而,虽然抗体的非中和细胞毒性功能与改善疾病结局和疫苗保护相关,但 VOC 对 Fc 效应功能的逃逸仍未得到明确界定。此外,VOC 是否像中和作用那样触发具有改变特异性的 Fc 功能尚不清楚。在这里,我们证明 Beta VOC 会部分逃避原始(D614G)变体感染个体中的 Fc 效应子活性。然而,并非所有功能都受到同等影响,这表明介导不同 Fc 功能的抗体具有不同的靶向性。此外,与 D614G 感染或 Ad26.COV2.S 疫苗接种个体相比,Beta 和 Delta 感染会引发对全球 VOC 具有显著改善的 Fc 交叉反应性的反应。这表明,与中和作用一样,感染的刺突序列会影响 Fc 效应子功能。这些数据对包含 VOC 的疫苗策略具有重要意义,表明这些策略可能会诱导更广泛的 Fc 效应子反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/3d18c23f59c6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/2a33ecd9455e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/9466d89df9de/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/e7a16b1d9c81/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/70d0462d9c56/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/3d18c23f59c6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/2a33ecd9455e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/9466d89df9de/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/e7a16b1d9c81/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/70d0462d9c56/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574a/8861829/3d18c23f59c6/gr4.jpg

相似文献

1
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity.SARS-CoV-2 Beta 和 Delta 变体通过增加交叉反应性触发 Fc 效应子功能。
Cell Rep Med. 2022 Jan 17;3(2):100510. doi: 10.1016/j.xcrm.2022.100510. eCollection 2022 Feb 15.
2
Fc effector cross-reactivity: A hidden arsenal against SARS-CoV-2's evasive maneuvering.Fc 效应器交叉反应性:对抗 SARS-CoV-2 逃避策略的隐藏武器。
Cell Rep Med. 2022 Feb 8;3(2):100540. doi: 10.1016/j.xcrm.2022.100540. eCollection 2022 Feb 15.
3
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern.mRNA-1273 疫苗诱导的抗体在整个 SARS-CoV-2 关注变异株中保持 Fc 效应功能。
Immunity. 2022 Feb 8;55(2):355-365.e4. doi: 10.1016/j.immuni.2022.01.001. Epub 2022 Jan 6.
4
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.SARS-CoV-2 奥密克戎、贝塔和德尔塔 plus 变体共享的 N417 依赖性表位。
J Virol. 2022 Aug 10;96(15):e0055822. doi: 10.1128/jvi.00558-22. Epub 2022 Jul 13.
5
Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities.异源 Ad26/Ad5 腺病毒载体疫苗诱导产生了具有强大 Fc 活性的 SARS-CoV-2 特异性抗体反应。
Front Immunol. 2024 May 8;15:1382619. doi: 10.3389/fimmu.2024.1382619. eCollection 2024.
6
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.Ad26.COV2.S 疫苗对人类 SARS-CoV-2 变异株的免疫原性。
Nature. 2021 Aug;596(7871):268-272. doi: 10.1038/s41586-021-03681-2. Epub 2021 Jun 9.
7
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner.先前感染 SARS-CoV-2 以依赖于变异体的方式增强和拓宽了 Ad26.COV2.S 的免疫原性。
Cell Host Microbe. 2021 Nov 10;29(11):1611-1619.e5. doi: 10.1016/j.chom.2021.10.003. Epub 2021 Oct 13.
8
Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.mRNA-1273 对 SARS-CoV-2 变异株的血清中和活性。
J Virol. 2021 Nov 9;95(23):e0131321. doi: 10.1128/JVI.01313-21. Epub 2021 Sep 22.
9
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.尽管存在延迟的动力学,但感染 SARS-CoV-2 或接种疫苗后,HIV 感染者也能获得等效的抗体功能。
Front Immunol. 2023 Aug 3;14:1231276. doi: 10.3389/fimmu.2023.1231276. eCollection 2023.
10
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.新冠病毒感染 14 个月后 COVID-19 恢复期患者结合抗体和中和抗体的动态分析。
Front Immunol. 2021 Nov 26;12:793953. doi: 10.3389/fimmu.2021.793953. eCollection 2021.

引用本文的文献

1
SARS-CoV-2 vaccines elicit differential Fc effector functions.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗引发不同的Fc效应器功能。
iScience. 2025 Jul 9;28(8):113084. doi: 10.1016/j.isci.2025.113084. eCollection 2025 Aug 15.
2
Applications and insights from continuous dengue virus infection in a stable cell line.稳定细胞系中持续登革病毒感染的应用与见解
Front Immunol. 2025 Jun 24;16:1618650. doi: 10.3389/fimmu.2025.1618650. eCollection 2025.
3
Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant.

本文引用的文献

1
Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity.逃避 SARS-CoV-2 变体刺突表位的识别,但总体上保持 T 细胞免疫。
Sci Transl Med. 2022 Feb 9;14(631):eabj6824. doi: 10.1126/scitranslmed.abj6824.
2
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern.由 COVID-19 mRNA 疫苗诱导产生的抗 SARS-CoV-2 抗体表现出独特的糖基化模式。
Cell Rep. 2021 Dec 14;37(11):110114. doi: 10.1016/j.celrep.2021.110114. Epub 2021 Nov 24.
3
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)IgG4增加会因Fc功能、Fc受体多态性和病毒变体而产生不同后果。
Sci Adv. 2025 Feb 28;11(9):eads1482. doi: 10.1126/sciadv.ads1482. Epub 2025 Feb 26.
4
Estimating SARS-CoV-2 Omicron XBB.1.5 Spike-Directed Functional Antibody Levels From an Anti-Receptor Binding Domain Wuhan-Hu-1-Based Commercial Immunoassay Results.基于抗武汉-胡-1受体结合域的商业免疫分析结果估算SARS-CoV-2奥密克戎XBB.1.5刺突定向功能性抗体水平
J Med Virol. 2025 Jan;97(1):e70130. doi: 10.1002/jmv.70130.
5
Induction of Fc-dependent functional antibodies against different variants of SARS-CoV-2 varies by vaccine type and prior infection.针对新冠病毒不同变体诱导产生依赖Fc的功能性抗体,其情况因疫苗类型和既往感染而有所不同。
Commun Med (Lond). 2024 Dec 19;4(1):273. doi: 10.1038/s43856-024-00686-6.
6
NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children.NK 细胞和单核细胞功能障碍在儿童多系统炎症综合征中的作用。
J Immunol. 2024 Nov 15;213(10):1452-1466. doi: 10.4049/jimmunol.2400395.
7
Beta Spike-Presenting SARS-CoV-2 Virus-like Particle Vaccine Confers Broad Protection against Other VOCs in Mice.呈现β峰的新型冠状病毒2型病毒样颗粒疫苗可对小鼠体内的其他变异株提供广泛保护。
Vaccines (Basel). 2024 Sep 2;12(9):1007. doi: 10.3390/vaccines12091007.
8
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.原发性 SARS-CoV-2 关注变体感染可引起广泛的抗体 Fc 介导的效应功能和记忆 B 细胞反应。
PLoS Pathog. 2024 Aug 15;20(8):e1012453. doi: 10.1371/journal.ppat.1012453. eCollection 2024 Aug.
9
Defining correlates of protection for mammalian livestock vaccines against high-priority viral diseases.定义针对高优先级病毒病的哺乳动物疫苗的保护相关因素。
Front Immunol. 2024 Jul 19;15:1397780. doi: 10.3389/fimmu.2024.1397780. eCollection 2024.
10
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.SARS-CoV-2 BA.4/5 感染在混合免疫背景下比 BA.1 引发更多的交叉反应性 FcγRIIIa 信号传导和中和作用。
J Virol. 2024 Jul 23;98(7):e0067824. doi: 10.1128/jvi.00678-24. Epub 2024 Jul 2.
先前感染 SARS-CoV-2 以依赖于变异体的方式增强和拓宽了 Ad26.COV2.S 的免疫原性。
Cell Host Microbe. 2021 Nov 10;29(11):1611-1619.e5. doi: 10.1016/j.chom.2021.10.003. Epub 2021 Oct 13.
4
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination.Fab 和 Fc 有助于对 SARS-CoV-2 进行最大程度的保护,采用 Matrix-M 疫苗的 NVX-CoV2373 亚单位疫苗。
Cell Rep Med. 2021 Sep 21;2(9):100405. doi: 10.1016/j.xcrm.2021.100405. Epub 2021 Aug 31.
5
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.针对多种高传染性 SARS-CoV-2 变体的超强效抗体。
Science. 2021 Aug 13;373(6556). doi: 10.1126/science.abh1766. Epub 2021 Jul 1.
6
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.SARS-CoV-2 mRNA 疫苗接种诱导针对 NTD、RBD 和 S2 的具有不同功能的抗体。
Cell. 2021 Jul 22;184(15):3936-3948.e10. doi: 10.1016/j.cell.2021.06.005. Epub 2021 Jun 8.
7
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses.单剂量的新冠病毒疫苗BNT162b2可引发Fc介导的抗体效应功能和T细胞反应。
Cell Host Microbe. 2021 Jul 14;29(7):1137-1150.e6. doi: 10.1016/j.chom.2021.06.001. Epub 2021 Jun 4.
8
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.Ad26.COV2.S 疫苗对人类 SARS-CoV-2 变异株的免疫原性。
Nature. 2021 Aug;596(7871):268-272. doi: 10.1038/s41586-021-03681-2. Epub 2021 Jun 9.
9
SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.SARS-CoV-2 关切变异株部分逃避 COVID-19 恢复期患者和疫苗接种者的体液但不逃避 T 细胞反应。
Sci Immunol. 2021 May 25;6(59). doi: 10.1126/sciimmunol.abj1750.
10
Decay of Fc-dependent antibody functions after mild to moderate COVID-19.轻度至中度 COVID-19 后 Fc 依赖性抗体功能的衰减。
Cell Rep Med. 2021 Jun 15;2(6):100296. doi: 10.1016/j.xcrm.2021.100296. Epub 2021 May 9.